Showing 41 - 50 of 2,979
We provide the first measurement of knowledge spillovers from venture capital-financed companies onto the patenting activities of other companies. On average, these spillovers are nine times larger than those generated by the R&D investment of established companies. Spillover effects are larger...
Persistent link: https://www.econbiz.de/10011762520
In this paper we measure knowledge spillovers arising from venture-capital financed companies on the patenting activities of other companies and compare them to spillovers from established firms. We develop a novel measure to to identify the appropriate spillover pool based on backward citations...
Persistent link: https://www.econbiz.de/10010482492
What national policies are most efficient in promoting the commercialization of university-generated knowledge? We address this question by characterizing and evaluating the policy pursued in Sweden and the US, two countries that put a great deal of resources into university R&D, but follow very...
Persistent link: https://www.econbiz.de/10001607835
The recent 'scientification' of commercial technology has brought the interface between universities and industry into sharp focus. In particular, academic entrepreneurship, i.e., the variety of ways in which academics take direct part in the commercialization of research, is widely discussed....
Persistent link: https://www.econbiz.de/10001600032
Measured by per-capita publication measures, Sweden is an academic powerhouse. Hence, its inability to commercialize on these accomplishments is a puzzle. This paper attributes this failure to the top-down nature of Swedish policies aimed at commercializing these innovations as well as an...
Persistent link: https://www.econbiz.de/10009502222
While most economists believe that public scientific research fuels industry innovation and economic growth, systematic evidence supporting this relationship is surprisingly limited. In a recent study, Acemoglu and Linn (2004) identified market size as a significant driver of drug innovation in...
Persistent link: https://www.econbiz.de/10009374417
This paper addresses the question of whether government procurement can work as a de facto innovation policy tool. We develop an endogenous growth model with quality-improving in-novation that incorporates industries with heterogeneous innovation sizes. Government de-mand in high-tech industries...
Persistent link: https://www.econbiz.de/10009271362
A merger between two innovation competitors is often suspected to reduce the variety of heterogeneous entities which are currently undertaking R&D or which are well situated to undertake R&D in a certain field. The consequential reduction of "diversity" can be detrimental to innovation because...
Persistent link: https://www.econbiz.de/10010226326
Firms play a central role in the selection, sponsorship, and employment of skilled immigrants entering the United States for work through programs like the H-1B visa. This role has not been widely recognized in the literature, and the data to better understand it have only recently become...
Persistent link: https://www.econbiz.de/10010371319
Persistent link: https://www.econbiz.de/10003863446